Clinical studies of urothelial carcinoma, thyroid cancer, colorectal cancer, and gastrointestinal stromal tumors indicated that CD26 expression is associated with distant metastasis or recurrence after resection [23, 25, 44]. This evidence concerns the gene DPP4 and gastrointestinal stromal tumor.